Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 486422-68-8 | MDL No. : | MFCD06659844 |
Formula : | C10H14BNO5S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | BRRALDPVXKGEEE-UHFFFAOYSA-N |
M.W : | 271.10 | Pubchem ID : | 44119546 |
Synonyms : |
|
Num. heavy atoms : | 18 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.4 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 6.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 69.56 |
TPSA : | 95.45 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -8.24 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | -0.4 |
Log Po/w (WLOGP) : | -0.91 |
Log Po/w (MLOGP) : | -1.3 |
Log Po/w (SILICOS-IT) : | -1.86 |
Consensus Log Po/w : | -0.89 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.32 |
Solubility : | 13.1 mg/ml ; 0.0481 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.14 |
Solubility : | 19.6 mg/ml ; 0.0723 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.4 |
Solubility : | 10.8 mg/ml ; 0.0398 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.61 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 486422-59-7 ]
4-(N,N-Dimethylsulfamoyl)phenylboronic acid
Similarity: 0.82
[ 913835-83-3 ]
(2-(Pyrrolidin-1-ylsulfonyl)phenyl)boronic acid
Similarity: 0.82
[ 957034-87-6 ]
(2-(Piperidin-1-ylsulfonyl)phenyl)boronic acid
Similarity: 0.81
[ 150691-04-6 ]
(2-(N-(tert-Butyl)sulfamoyl)phenyl)boronic acid
Similarity: 0.74
[ 613660-87-0 ]
(4-Aminosulfonylphenyl)boronic acid
Similarity: 0.69
[ 486422-59-7 ]
4-(N,N-Dimethylsulfamoyl)phenylboronic acid
Similarity: 0.82
[ 913835-83-3 ]
(2-(Pyrrolidin-1-ylsulfonyl)phenyl)boronic acid
Similarity: 0.82
[ 957034-87-6 ]
(2-(Piperidin-1-ylsulfonyl)phenyl)boronic acid
Similarity: 0.81
[ 150691-04-6 ]
(2-(N-(tert-Butyl)sulfamoyl)phenyl)boronic acid
Similarity: 0.74
[ 933989-32-3 ]
3-(Morpholine-4-sulfonyl)benzylamine
Similarity: 0.72
[ 486422-59-7 ]
4-(N,N-Dimethylsulfamoyl)phenylboronic acid
Similarity: 0.82
[ 913835-83-3 ]
(2-(Pyrrolidin-1-ylsulfonyl)phenyl)boronic acid
Similarity: 0.82
[ 957034-87-6 ]
(2-(Piperidin-1-ylsulfonyl)phenyl)boronic acid
Similarity: 0.81
[ 150691-04-6 ]
(2-(N-(tert-Butyl)sulfamoyl)phenyl)boronic acid
Similarity: 0.74
[ 933989-32-3 ]
3-(Morpholine-4-sulfonyl)benzylamine
Similarity: 0.72
[ 913835-83-3 ]
(2-(Pyrrolidin-1-ylsulfonyl)phenyl)boronic acid
Similarity: 0.82
[ 957034-87-6 ]
(2-(Piperidin-1-ylsulfonyl)phenyl)boronic acid
Similarity: 0.81
[ 933989-32-3 ]
3-(Morpholine-4-sulfonyl)benzylamine
Similarity: 0.72
[ 1154310-76-5 ]
2-(4-((2-Aminophenyl)sulfonyl)piperazin-1-yl)ethanol
Similarity: 0.67
[ 13573-28-9 ]
6-Tosyl-2-oxa-6-azaspiro[3.3]heptane
Similarity: 0.62
[ 933989-32-3 ]
3-(Morpholine-4-sulfonyl)benzylamine
Similarity: 0.72
[ 941717-06-2 ]
4-((2-(Bromomethyl)phenyl)sulfonyl)morpholine
Similarity: 0.69